Ratings Haleon plc Nyse

Equities

HLN

US4055521003

Market Closed - Nyse Other stock markets 01:30:02 22/05/2024 am IST			5-day change	1st Jan Change
8.52 ^USD	+0.12%		+2.40%	+3.52%

21/05	Bernstein becomes more optimistic for consumer goods - Henkel upgraded	DP
17/05	UK's FTSE 100 Closes Lower Amid Inflation Focus	MT

Strengths

Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
The group's high margin levels account for strong profits.
Analysts covering this company mostly recommend stock overweighting or purchase.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.
There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.

Weaknesses

With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
The company is in debt and has limited leeway for investment
The company's enterprise value to sales, at 3.33 times its current sales, is high.

Ratings chart - Surperformance

Sector: Pharmaceuticals

	1st Jan change	Capi.	ESG Refinitiv
HALEON PLC	+3.52%	38.49B	-
ELI LILLY AND COMPANY	+37.78%	723B	C+
NOVO NORDISK A/S	+31.54%	598B	B
JOHNSON & JOHNSON	-3.51%	364B	C+
MERCK & CO., INC.	+19.94%	331B	B-
ABBVIE INC.	+5.14%	288B	C+
ASTRAZENECA PLC	+15.98%	244B	B+
ROCHE HOLDING AG	-4.42%	208B	A+
NOVARTIS AG	+10.10%	210B	B-
AMGEN INC.	+9.32%	169B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes